○Kei-ichi Uchiya, Masahiro Ando (Dept. Microbiol., Fac. Pharm., Meijo Univ.)

○Ken Yoshii^1,2, Koji Hosomi¹, Atsushi Shimoyama³, Yunru Wang^1,4, Haruki Yamaura³, Takahiro Nagatake¹, Hidehiko Suzuki¹, Huangwenxian Lan^1,4, Hiroshi Kiyono^5,6,7,8, Koichi Fukase³, Jun Kunisawa^{1,2,4,5,9,10,11,12} (¹The Laboratory of Vaccine Materials., NIBIOHN., ²Grad. Sch. Med., Osaka Univ., ³Grad Sch. Sci., Osaka Univ., ⁴Grad Sch. Pharmaceutical Sci., Osaka Univ., ⁵International Research and Development Center for Mucosal Vaccines, IMSUT., ⁶Dept. Mucosal Immunol., IMSUT Distinguished Professor Unit., IMSUT., ⁷Dept. Gastroenterology., Sch. Med and CU-UCSD Center for Mucosal Immunology, Allergy and Vaccine., Univ. California., ⁸Grad Sch. Med., Chiba Univ., ⁹Grad Sch. Dent., Osaka Univ., ¹⁰Grad Sch. Med., Kobe Univ., ¹¹Grad Sch. Biomedical and Health Sci., Hiroshima Univ., ¹²Research Organization for Nano & Life Innovation., Waseda Univ.)

○Nao Yamazaki¹, Shinji Mima¹, Yuki Imakura¹, Takahiro Iwao², Tamihide Matsunaga², Shinichi Watanabe¹, Kozo Nagata¹, Masahiko Taniguchi¹ (¹Bio Science & Engineering Laboratory, FUJIFILM Corporation, ²Dept. Clinical Pharmacy, Grad. Sch. Pharmaceutical Sciences, Nagoya City Univ.)

Keiichi Taniguchi¹, Daisuke Hayashi², Naomi Yasuda³, Mao Nakayama³, Saotomo Itoh¹, Saburo Yamamoto², Naoya Ohara⁴, Shigeaki Hida¹, Kikuo Onozaki¹, ○Takemasa Takii^1,3 (¹Dept. Molecular Health Sciences, Grad. Sch. Pharmaceutical Sciences, Nagoya City Univ., ²Japan BCG Laboratory, ³Dept. Mycobacterium Reference and Research, The Research Institute of Tuberculosis, Japan Anti-Tuberculosis Association, ⁴Dept. Oral Microbiology, Grad. Sch. Medicine, Dentistry, and Pharmaceutical Sciences, Okayama Univ.)

○Momoko Nakayama, Swarmistha Devi Aribam, Yohsuke Ogawa, Yoshihiro Shimoji, Masahiro Eguchi (NIAH, NARO)

○Koichiro Fujii¹, Kosuke Fujimoto^1,2,3, Satoshi Uematsu^1,2,3 (¹Dept. Immunology and Genomics, Osaka City Univ. Grad. Sch. Medicine, ²Div. Metagenome Medicine, Human Genome Center, The Institute of Medical Science, The Univ. of Tokyo, ³Div. Innate Immune Regulation, International Research and Development Center for Mucosal Vaccine, The Institute of Medical Science, The Univ. of Tokyo)

○Tsuyoshi Takata¹, Tomoaki Ida¹, Tetsuro Matsunaga¹, Masanobu Morita¹, Yukihiro Tsuchiya², Yasuo Watanabe², Hideki Sumimoto³, Hozumi Motohashi⁴, Takaaki Akaike¹ (¹Dept. Environ. Med. Mol. Toxicol., Tohoku Univ., Grad. Sch. Med., ²Dept. Pharm., Showa Pharm. Univ., ³Dept. Biochem., Kyushu Univ., Grad. Sch. Med. Sci., ⁴Dept. Gene Exp. Reg., IDAC, Tohoku Univ.)

○Shota Torigoe¹, Akira Kawano², Satoru Mizuno², Kazuhiro Matsuo², Sho Yamasaki^1,3,4,5 (¹Dept. Mol. Immunol., RIMD, Osaka Univ., ²Japan BCG Laboratory, ³Lab. Mol. Immunol., IFReC, Osaka Univ., ⁴Div. Mol. Immunol., MIB, Kyushu Univ., ⁵Div. Mol. Immunol. MMRC, Chiba Univ.)

○Takehiro Yamaguchi¹, Ryoma Nakao², Shuhei Tomita¹ (¹Dept. Pharmacol., Sch. Med., Osaka City Univ., ²Dept. Bacteriol. I, Natl. Inst. Infect. Dis.)

○Masaaki Yoshida¹, Tetsuro Matsunaga¹, Tsuyoshi Takata¹, Tomoaki Ida¹, Masato Tsutsui², Masanobu Morita¹, Tomohiro Sawa³, Takaaki Akaike¹ (¹Dept. Environ. Med. Mol. Toxicol., Tohoku Univ. Grad. Sch. Med., ²Dept. Pharmacol., Grad. Sch. Med., Univ. the Ryukyus, ³Dept. Microbiol., Grad. Sch. Med. Sci., Kumamoto Univ.)

○Kohsuke Tsuchiya, Takashi Suda (Div. Immunol., Cancer Res. Inst., Kanazawa Univ.)

○Mayu Kitamura, Takuhiro Matsumura, Sho Amatsu, Masahiro Yutani, Chiyono Morimoto, Yukako Fujinaga (Dept. Microbiol., Sch. Med. Sci., Kanazawa Univ.)